196 related articles for article (PubMed ID: 1919901)
41. Serum anticapsular antibody response in the first week after immunization of adults and infants with the Haemophilus influenzae type b-Neisseria meningitidis outer membrane protein complex conjugate vaccine.
Daum RS; Siber GR; Ballanco GA; Sood SK
J Infect Dis; 1991 Dec; 164(6):1154-9. PubMed ID: 1955715
[TBL] [Abstract][Full Text] [Related]
42. Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide.
Moreno C; Lifely MR; Esdaile J
Infect Immun; 1985 Feb; 47(2):527-33. PubMed ID: 3917979
[TBL] [Abstract][Full Text] [Related]
43. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.
Kurikka S; Käyhty H; Saarinen L; Rönnberg PR; Eskola J; Mäkelä PH
J Infect Dis; 1995 Nov; 172(5):1268-72. PubMed ID: 7594663
[TBL] [Abstract][Full Text] [Related]
44. Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults.
Insel RA; Kittelberger A; Anderson P
J Immunol; 1985 Oct; 135(4):2810-6. PubMed ID: 3897378
[TBL] [Abstract][Full Text] [Related]
45. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.
Granoff DM; Holmes SJ; Osterholm MT; McHugh JE; Lucas AH; Anderson EL; Belshe RB; Jacobs JL; Medley F; Murphy TV
J Infect Dis; 1993 Sep; 168(3):663-71. PubMed ID: 8354908
[TBL] [Abstract][Full Text] [Related]
46. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes.
Liu MA; Friedman A; Oliff AI; Tai J; Martinez D; Deck RR; Shieh JT; Jenkins TD; Donnelly JJ; Hawe LA
Proc Natl Acad Sci U S A; 1992 May; 89(10):4633-7. PubMed ID: 1533934
[TBL] [Abstract][Full Text] [Related]
47. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
48. Additional dose urged for some receiving Haemophilus influenzae vaccine in early '90s.
Marwick C
JAMA; 1992 Dec; 268(23):3287. PubMed ID: 1453513
[No Abstract] [Full Text] [Related]
49. Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants.
Bryant KA; Marshall GS; Marchant CD; Pavia-Ruiz N; Nolan T; Rinderknecht S; Blatter M; Aris E; Lestrate P; Boutriau D; Friedland LR; Miller JM
Pediatrics; 2011 Jun; 127(6):e1375-85. PubMed ID: 21624883
[TBL] [Abstract][Full Text] [Related]
50. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
Schlesinger Y; Granoff DM
JAMA; 1992 Mar; 267(11):1489-94. PubMed ID: 1538539
[TBL] [Abstract][Full Text] [Related]
51. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
52. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
53. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
Blanchard-Rohner G; Pollard AJ
Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
[TBL] [Abstract][Full Text] [Related]
54. [The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration].
Basnak'ian IA; Alliluev AP; Kuvakina VI; Aleksakhina NN; Kotel'nikova OV; Chulok TA; Karabak Vi; Borovkova VM; Valerius II; Gofman IL
Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):66-7. PubMed ID: 7879546
[No Abstract] [Full Text] [Related]
55. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
56. Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group.
Black SB; Shinefield HR; Lampert D; Fireman B; Hiatt RA; Polen M; Vittinghoff E
Pediatr Infect Dis J; 1991 Feb; 10(2):92-6. PubMed ID: 2062620
[TBL] [Abstract][Full Text] [Related]
57. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
58. H. influenzae vaccine for infants.
Med Lett Drugs Ther; 1991 Jan; 33(836):5-7. PubMed ID: 1986208
[No Abstract] [Full Text] [Related]
59. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
60. Persistent urinary antigen excretion in infants vaccinated with Haemophilus influenzae type b capsular polysaccharide conjugated with outer membrane protein from Neisseria meningitidis.
Goepp JG; Hohenboken M; Almeido-Hill J; Santosham M
Pediatr Infect Dis J; 1992 Jan; 11(1):2-5. PubMed ID: 1549403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
